Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
about
Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomasThe membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cellsIncreased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progressionStructural plasticity of perisynaptic astrocyte processes involves ezrin and metabotropic glutamate receptors.The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.Screening differentially expressed genes in mouse hepatocarcinoma ascites cell line with high potential of lymphatic metastasis.Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene.Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells.Ezrin promotes invasion and metastasis of pancreatic cancer cells.Baicalein mediates inhibition of migration and invasiveness of skin carcinoma through Ezrin in A431 cellsEzrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells.A functional association between merlin and HEI10, a cell cycle regulator.ß1 integrin binding phosphorylates ezrin at T567 to activate a lipid raft signalsome driving invadopodia activity and invasionSubcellular distribution and expression of cofilin and ezrin in human colon adenocarcinoma cell lines with different metastatic potentialUpregulated expression of Ezrin and invasive phenotype in malignantly transformed esophageal epithelial cellsEzrin Inhibition Up-regulates Stress Response Gene ExpressionTwo cases of primary malignant fibrous histiocytoma of the liver: immunohistochemical expression of ezrin and its relationship with prognosis.Glutamine synthetase as an astrocytic marker: its cell type and vesicle localizationSystematic review of protein biomarkers of invasive behavior in glioblastoma.MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion.Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro.Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment.Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.Src phosphorylates ezrin at tyrosine 477 and induces a phosphospecific association between ezrin and a kelch-repeat protein family member.Co-operative effect of c-Src and ezrin in deregulation of cell-cell contacts and scattering of mammary carcinoma cells.Correlation of in vitro infiltration with glioma histological type in organotypic brain slices.Expression and functional significance of ezrin in human brain astrocytoma.Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.Exposure to environmental enrichment prior to a cerebral cortex stab wound attenuates the postlesional astroglia response in rats.Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase-1.Pleiotropic function of ezrin in human metastatic melanomas.Increase in ezrin expression from benign to malignant breast tumours.Prognostic implication of ezrin overexpression in myxofibrosarcomas.Altered expression of ezrin in esophageal squamous cell carcinoma.Mesenchymal stem cells enhance tumorigenic properties of human glioblastoma through independent cell-cell communication mechanisms.Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma.
P2860
Q24656634-C9027F1C-1BB8-4F1F-8D23-D5AC352B45C0Q24810263-C8EE2CE7-9442-4DD4-90D7-F9D28AD5C71BQ28305905-053F9121-DB3C-4634-9216-DB4B33DAF8DDQ28582615-D169D338-5E7F-4D6B-9765-D8C77F1FCB80Q30651861-BCCBB0E0-5050-4690-BFF4-29412D56EB83Q31156673-B94D1386-F232-4014-95E4-37C86D761348Q33532354-141E98FD-55CE-407E-9144-6676DBA5CD4DQ33698044-F694ADF2-2BDB-4D42-B991-579899036FF4Q33943320-CCE38FE7-12D2-4831-90C9-5D1BD9C562F2Q34047483-965F0BED-5950-4AD9-A44F-47266BA8923FQ34112988-EA2BBFED-AF48-4DF4-B4E4-6C1B10A948BFQ34187445-FEF9217F-5A6D-4A76-BD16-29725063F30EQ34501518-F93EBA7B-C722-44B9-A365-8B15DD657500Q35005380-D1ED87CB-C945-4372-87DC-F0BB0F26C15FQ35197224-0C3BC8DC-62D2-487F-BF11-A43640F3CC53Q36179753-4D585DBD-5412-45E5-AF3E-E09EF506986AQ37065917-6F9DDD19-84C4-4BE8-A46D-DB262495D3ADQ37263471-063B03B9-1BB6-4650-B3AA-5256972A03A1Q38153690-61737D17-D1F0-491F-96CC-94A13D2BEDD4Q38165795-55CD46AA-9F21-4C9B-BB8B-805424BCD0CEQ38972375-6B8AF89E-E340-4F90-8BA7-31C1C3392C27Q39189513-AEC45668-3299-4D31-A6B4-11E5C4454377Q39525953-3EDC0742-71A2-4A7A-9EEA-C385D2FC2D0CQ39739259-75957AAF-05E6-4DB4-9655-22C9D6442541Q39817880-00722D43-CD6A-4F04-88D5-D29C943B7ADBQ39904552-435729B4-46FD-430D-B17A-54ED43D42824Q40304710-AE822EAB-DB82-4392-9986-927D6C025157Q40476423-B02B4B3C-5730-4860-8241-EBA1944A9EAEQ40564974-C42D0A49-C7FC-422F-A637-C86FE1E97DD5Q42157104-AAEE87B1-BC51-4002-8824-F16E0D030CF3Q43636980-B407D938-E5D8-461D-872E-C9BE55E8AB2FQ47183915-3BE0F0A8-F291-4A2D-BB7F-E75898A6DF5EQ48416282-7B2C800E-E23C-497C-BCBF-A94D89C14664Q48912859-E99A9763-EB5A-423B-88CE-A6026EFF2CEAQ51805729-29FC5E00-9BEA-4DD1-84C7-ADD096534A6EQ53086422-7BE95C20-7A6C-4991-8F8B-AF62E1AE89F9Q54422168-6284946F-8E88-49C9-B641-B2DC8AE011F9Q54610607-0FF795EE-66AA-4FC1-AC6B-F68051024FA9Q55379731-98107589-F35F-419A-B7E2-FFFE7467DEC7Q55471244-F098DBFE-936F-4F68-B05D-E25E412FE486
P2860
Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@en
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@nl
type
label
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@en
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@nl
prefLabel
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@en
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@nl
P2093
P2860
P1476
Ezrin immunoreactivity is asso ...... absent in oligodendrogliomas.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)64816-X
P407
P577
2000-12-01T00:00:00Z